SYNOPSYS INC (SYP.DE) Fundamental Analysis & Valuation

FRA:SYP • US8716071076

366.45 EUR
-4.25 (-1.15%)
Last: Mar 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SYP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

SYP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 121 industry peers in the Software industry. While SYP is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, SYP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. SYP.DE Profitability Analysis

1.1 Basic Checks

  • SYP had positive earnings in the past year.
  • SYP had a positive operating cash flow in the past year.
  • SYP had positive earnings in each of the past 5 years.
  • SYP had a positive operating cash flow in each of the past 5 years.
SYP.DE Yearly Net Income VS EBIT VS OCF VS FCFSYP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B -15B

1.2 Ratios

  • The Return On Assets of SYP (2.33%) is comparable to the rest of the industry.
  • SYP has a Return On Equity of 3.61%. This is comparable to the rest of the industry: SYP outperforms 45.45% of its industry peers.
  • SYP's Return On Invested Capital of 1.60% is in line compared to the rest of the industry. SYP outperforms 47.93% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SYP is significantly below the industry average of 13.12%.
  • The last Return On Invested Capital (1.60%) for SYP is well below the 3 year average (7.77%), which needs to be investigated, but indicates that SYP had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.33%
ROE 3.61%
ROIC 1.6%
ROA(3y)10.66%
ROA(5y)10.22%
ROE(3y)16.63%
ROE(5y)16.41%
ROIC(3y)7.77%
ROIC(5y)8.83%
SYP.DE Yearly ROA, ROE, ROICSYP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • SYP's Profit Margin of 13.76% is fine compared to the rest of the industry. SYP outperforms 63.64% of its industry peers.
  • In the last couple of years the Profit Margin of SYP has remained more or less at the same level.
  • With a decent Operating Margin value of 12.29%, SYP is doing good in the industry, outperforming 61.16% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SYP has declined.
  • SYP has a Gross Margin (75.14%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of SYP has remained more or less at the same level.
Industry RankSector Rank
OM 12.29%
PM (TTM) 13.76%
GM 75.14%
OM growth 3Y-19.79%
OM growth 5Y-5.43%
PM growth 3Y-3.98%
PM growth 5Y0.93%
GM growth 3Y-1.5%
GM growth 5Y-0.37%
SYP.DE Yearly Profit, Operating, Gross MarginsSYP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SYP.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SYP is destroying value.
  • SYP has more shares outstanding than it did 1 year ago.
  • SYP has more shares outstanding than it did 5 years ago.
  • SYP has a worse debt/assets ratio than last year.
SYP.DE Yearly Shares OutstandingSYP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
SYP.DE Yearly Total Debt VS Total AssetsSYP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.50 indicates that SYP is not in any danger for bankruptcy at the moment.
  • SYP's Altman-Z score of 3.50 is fine compared to the rest of the industry. SYP outperforms 60.33% of its industry peers.
  • A Debt/Equity ratio of 0.33 indicates that SYP is not too dependend on debt financing.
  • SYP has a worse Debt to Equity ratio (0.33) than 60.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 3.5
ROIC/WACC0.15
WACC10.73%
SYP.DE Yearly LT Debt VS Equity VS FCFSYP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B

2.3 Liquidity

  • SYP has a Current Ratio of 1.36. This is a normal value and indicates that SYP is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.36, SYP perfoms like the industry average, outperforming 47.11% of the companies in the same industry.
  • A Quick Ratio of 1.26 indicates that SYP should not have too much problems paying its short term obligations.
  • The Quick ratio of SYP (1.26) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.26
SYP.DE Yearly Current Assets VS Current LiabilitesSYP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SYP.DE Growth Analysis

3.1 Past

  • SYP shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.77%.
  • SYP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.54% yearly.
  • SYP shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.88%.
  • The Revenue has been growing by 13.87% on average over the past years. This is quite good.
EPS 1Y (TTM)6.77%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%24.42%
Revenue 1Y (TTM)31.88%
Revenue growth 3Y15.19%
Revenue growth 5Y13.87%
Sales Q2Q%65.52%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.44% on average over the next years. This is quite good.
  • SYP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.92% yearly.
EPS Next Y13.4%
EPS Next 2Y15.87%
EPS Next 3Y17.01%
EPS Next 5Y14.44%
Revenue Next Year36.69%
Revenue Next 2Y23.02%
Revenue Next 3Y18.92%
Revenue Next 5Y14.92%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYP.DE Yearly Revenue VS EstimatesSYP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SYP.DE Yearly EPS VS EstimatesSYP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

1

4. SYP.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • SYP is valuated quite expensively with a Price/Earnings ratio of 30.82.
  • Compared to the rest of the industry, the Price/Earnings ratio of SYP is on the same level as its industry peers.
  • SYP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.71.
  • SYP is valuated rather expensively with a Price/Forward Earnings ratio of 24.26.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SYP is on the same level as its industry peers.
  • SYP's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 30.82
Fwd PE 24.26
SYP.DE Price Earnings VS Forward Price EarningsSYP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SYP is valued a bit more expensive than the industry average as 61.98% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 43.38
SYP.DE Per share dataSYP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SYP does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as SYP's earnings are expected to grow with 17.01% in the coming years.
PEG (NY)2.3
PEG (5Y)1.66
EPS Next 2Y15.87%
EPS Next 3Y17.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SYP.DE Dividend Analysis

5.1 Amount

  • No dividends for SYP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SYP.DE Fundamentals: All Metrics, Ratios and Statistics

SYNOPSYS INC

FRA:SYP (3/12/2026, 7:00:00 PM)

366.45

-4.25 (-1.15%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners90.86%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap70.20B
Revenue(TTM)8.01B
Net Income(TTM)1.10B
Analysts80
Price Target480.24 (31.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.14%
Min EPS beat(2)2.36%
Max EPS beat(2)3.92%
EPS beat(4)3
Avg EPS beat(4)0.41%
Min EPS beat(4)-10.9%
Max EPS beat(4)6.25%
EPS beat(8)6
Avg EPS beat(8)1.17%
EPS beat(12)9
Avg EPS beat(12)1.05%
EPS beat(16)13
Avg EPS beat(16)1.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.41%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)-1.2%
Revenue beat(8)0
Avg Revenue beat(8)-2.19%
Revenue beat(12)0
Avg Revenue beat(12)-1.93%
Revenue beat(16)0
Avg Revenue beat(16)-4.49%
PT rev (1m)-2.56%
PT rev (3m)0.32%
EPS NQ rev (1m)1.95%
EPS NQ rev (3m)-0.17%
EPS NY rev (1m)0.46%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)0.7%
Revenue NQ rev (3m)-2.17%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 30.82
Fwd PE 24.26
P/S 10.12
P/FCF N/A
P/OCF 33.18
P/B 2.65
P/tB N/A
EV/EBITDA 43.38
EPS(TTM)11.89
EY3.24%
EPS(NY)15.1
Fwd EY4.12%
FCF(TTM)-65.11
FCFYN/A
OCF(TTM)11.04
OCFY3.01%
SpS36.2
BVpS138.11
TBVpS-38.98
PEG (NY)2.3
PEG (5Y)1.66
Graham Number192.22
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 3.61%
ROCE 2.27%
ROIC 1.6%
ROICexc 1.69%
ROICexgc 36.07%
OM 12.29%
PM (TTM) 13.76%
GM 75.14%
FCFM N/A
ROA(3y)10.66%
ROA(5y)10.22%
ROE(3y)16.63%
ROE(5y)16.41%
ROIC(3y)7.77%
ROIC(5y)8.83%
ROICexc(3y)10.92%
ROICexc(5y)12.04%
ROICexgc(3y)46.31%
ROICexgc(5y)58.99%
ROCE(3y)11.04%
ROCE(5y)12.54%
ROICexgc growth 3Y-30.11%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y-54.14%
ROICexc growth 5Y-30.5%
OM growth 3Y-19.79%
OM growth 5Y-5.43%
PM growth 3Y-3.98%
PM growth 5Y0.93%
GM growth 3Y-1.5%
GM growth 5Y-0.37%
F-Score3
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 4.89
Cap/Depr 1584.42%
Cap/Sales 210.37%
Interest Coverage 250
Cash Conversion 119.31%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.26
Altman-Z 3.5
F-Score3
WACC10.73%
ROIC/WACC0.15
Cap/Depr(3y)948.17%
Cap/Depr(5y)656.53%
Cap/Sales(3y)84.22%
Cap/Sales(5y)54.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.77%
EPS 3Y13.39%
EPS 5Y18.54%
EPS Q2Q%24.42%
EPS Next Y13.4%
EPS Next 2Y15.87%
EPS Next 3Y17.01%
EPS Next 5Y14.44%
Revenue 1Y (TTM)31.88%
Revenue growth 3Y15.19%
Revenue growth 5Y13.87%
Sales Q2Q%65.52%
Revenue Next Year36.69%
Revenue Next 2Y23.02%
Revenue Next 3Y18.92%
Revenue Next 5Y14.92%
EBIT growth 1Y-21.56%
EBIT growth 3Y-7.6%
EBIT growth 5Y7.68%
EBIT Next Year39.09%
EBIT Next 3Y29.79%
EBIT Next 5Y15.51%
FCF growth 1Y-1620.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.78%
OCF growth 3Y-4.41%
OCF growth 5Y8.9%

SYNOPSYS INC / SYP.DE FAQ

What is the ChartMill fundamental rating of SYNOPSYS INC (SYP.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SYP.DE.


What is the valuation status for SYP stock?

ChartMill assigns a valuation rating of 1 / 10 to SYNOPSYS INC (SYP.DE). This can be considered as Overvalued.


How profitable is SYNOPSYS INC (SYP.DE) stock?

SYNOPSYS INC (SYP.DE) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for SYP stock?

The Price/Earnings (PE) ratio for SYNOPSYS INC (SYP.DE) is 30.82 and the Price/Book (PB) ratio is 2.65.


How financially healthy is SYNOPSYS INC?

The financial health rating of SYNOPSYS INC (SYP.DE) is 3 / 10.